<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Physiology and Pharmacology</title>
<title_fa></title_fa>
<short_title>Physiol Pharmacol</short_title>
<subject>Medical Sciences</subject>
<web_url>http://ppj.phypha.ir</web_url>
<journal_hbi_system_id>32</journal_hbi_system_id>
<journal_hbi_system_user>journal32</journal_hbi_system_user>
<journal_id_issn>24765236</journal_id_issn>
<journal_id_issn_online>24765244</journal_id_issn_online>
<journal_id_pii></journal_id_pii>
<journal_id_doi>10.22034</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid>(previous ISSN: 17350581)</journal_id_sid>
<journal_id_nlai></journal_id_nlai>
<journal_id_science></journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1399</year>
	<month>3</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2020</year>
	<month>6</month>
	<day>1</day>
</pubdate>
<volume>24</volume>
<number>2</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>Effect of simvastatin on c-myc, cyclin D1 and p53 expression in DMBA-induced breast cancer in mice</title>
	<subject_fa>Cell, Stem Cell and Cancer</subject_fa>
	<subject>Cell, Stem Cell and Cancer</subject>
	<content_type_fa>Experimental research article</content_type_fa>
	<content_type>Experimental research article</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;div style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;Introduction:&lt;/strong&gt; Recently, the therapeutic and antioxidant effects of simvastatin on 7,12-dimethylbenz[a] anthracene (DMBA) induced breast cancer have been studied. To gain further understanding of the molecular mechanisms of simvastatin, this study investigated its effects on the expression of c-myc, cyclin D1 and p53 in normal mammary glands and tumors. &lt;strong&gt;Methods:&lt;/strong&gt; Female albino mice were divided into two groups: 1) N group, healthy mice without DMBA and 2) D group, mice with DMBA administration. After the appearance of tumors, D group mice are subdivided into 3 groups, as control (C), simvastatin- treated group (S) which received 80 mg/kg/day, orally and tamoxifen-treated group (T) with 50 mg/kg/day, orally. After 4 weeks, animals were sacrificed. Also, the tumors and normal mammary glands were removed for histopathological evaluations and analysis of gene expression by qRT-PCR. &lt;strong&gt;Results:&lt;/strong&gt; The results showed the up-regulation of c-myc and cyclin D1 in tumors of the control group compared with mammary glands of the N group. Similar to tamoxifen, the simvastatin treatment could normalize the expression of c-myc and cyclin D1; however, the expression of p53 did not change in the treated groups. &lt;strong&gt;Conclusion:&lt;/strong&gt; Down-regulation of c-myc and cyclin D1 in treated tumors with simvastatin could be a possible molecular mechanism for its therapeutic effects in DMBA-induced breast cancer in mice.&lt;/div&gt;
</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Breast cancer, Simvastatin, Cyclin D1, C-myc, P53.</keyword>
	<start_page>152</start_page>
	<end_page>158</end_page>
	<web_url>http://ppj.phypha.ir/browse.php?a_code=A-10-1297-1&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Behnaz</first_name>
	<middle_name></middle_name>
	<last_name>Karimi</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>3200319475328460029429</code>
	<orcid>3200319475328460029429</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Division of Biochemistry, Department of Basic Sciences, School of Veterinary Medicine, Shiraz University, Shiraz, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Mahboobeh</first_name>
	<middle_name></middle_name>
	<last_name>Ashrafi</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>mashrafi@shirazu.ac.ir</email>
	<code>3200319475328460029430</code>
	<orcid>3200319475328460029430</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Division of Biochemistry, Department of Basic Sciences, School of Veterinary Medicine, Shiraz University, Shiraz, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Malihe</first_name>
	<middle_name></middle_name>
	<last_name>Masoudian</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>3200319475328460029431</code>
	<orcid>3200319475328460029431</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Division of Biotechnology, Department of Pathobiology, School of Veterinary Medicine, Shiraz University, Shiraz, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
